Home World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic... World News Nivolumab Plus AVD Prolongs PFS in Adolescents and Adults with Advanced-Stage Classic Hodgkin’s Lymphoma By Ogkologos - October 30, 2024 3126 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the S1826 study Source RELATED ARTICLESMORE FROM AUTHOR New on NCI’s Websites for November 2024 A Short-Course of Induction Chemotherapy Followed by Chemoradiotherapy Significantly Improves Survival in Patients with Locally Advanced Cervical Cancer Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer MOST POPULAR What to Know About Cancer Clinical Trial Matching Programs March 14, 2023 Pembrolizumab Improves Survival in Advanced Triple-Negative Breast Cancer August 9, 2022 When Both Tumour-Infiltrating Lymphocytes and Gene Expression are Available, the Prognostic... January 23, 2023 Zucchini everywhere October 9, 2020 Load more HOT NEWS Efficacy of Sunitinib in Patients with Metastatic Phaeochromocytomas and Paragangliomas Loving Yourself Indigenous Women with Early Stage Breast Cancer Get Mastectomies at Higher... FDA Grants Accelerated Approval to Ponatinib with Chemotherapy for Newly Diagnosed...
